|
September
2008 Off
the Wire . . .
|
| Date
|
Title
|
| 09-01-08
|
New
Quality Assurance On The Way For Health And Social Care Information, UK
|
| 09-03-08
|
Multiple
Sclerosis - Jeffery D. Kocsis, Ph.D. And Wayne State Graduate To
Receive The Da Vinci Lifetime Achievement Award
|
| 09-04-08
|
MS
Market Is Estimated To Be Worth Almost US$8 Billion In 2008, With A
Growth Rate Of 10.6% Year-On-Year
|
| 09-04-08
|
Regulatory
Immune Cells Not Defective In Multiple Sclerosis
|
| 09-04-08
|
UPDATE
2-BioMS multiple sclerosis drug gets FDA fast track
|
| 09-05-08
|
Opexa
Therapeutics And Myelin Repair Foundation Partner On Novel Multiple
Sclerosis Research Program
|
| 09-05-08
|
Early
relapses after the first dose of natalizumab in active multiple
sclerosis patients
|
| 09-05-08
|
Outcome
measures for trials of remyelinating agents in multiple sclerosis:
retrospective longitudinal analysis of visual evoked potential latency
|
| 09-06-08
|
IMPAX
Reports Positive Results in Phase III Trial with IPX056
|
| 09-09-08
|
2008
Da Vinci Awards For Wheelchair Enhancing Ideas - National MS Society
Celebrating New Adaptive, Assistive Technologies
|
| 09-09-08
|
Sports-Cheat
Drug Enhances Memory
|
| 09-10-08
|
Neural
Cells Derived From Human Embryonic Stem Cells Reduce Multiple Sclerosis
Symptoms
|
| 09-13-08
|
Positive
Results From Small Study Assessing The Safety Of LDN, UK |
| 09-13-08
|
Sativex
Study Confirms Long Term Effectiveness In MS Neuropathic Pain |
| 09-15-08
|
New
Research Shows Progress Towards Reversing Nerve Damage |
| 09-15-08
|
Acorda
Therapeutics To Present Phase 3 Fampridine-SR Data At World Congress On
Treatment And Research In Multiple Sclerosis Meeting |
| 09-16-08
|
Betaseron(R)
To Offer The Thinnest Needle In Multiple Sclerosis |
| 09-17-08
|
Scottish
Research Highlights Possible Role Of Vitamin D In MS |
| 09-17-08
|
Funding
From The NIH For Multiple Disease-Related Research |
| 09-17-08
|
Teva
To Present New Treatment Data At World Congress For Multiple Sclerosis
|
| 09-18-08
|
Major
Study Shows MS Is A Global Disease
|
| 09-19-08
|
EndMS
Speeds Research Effort, Pushes To Cure Multiple Sclerosis
|
| 09-19-08
|
Merck
Serono Announces Initiation Of The ORACLE MS Trial To Evaluate
Cladribine Tablets In Patients At Risk Of Developing Multiple Sclerosis
|
| 09-19-08
|
Longest
Prospective Study In MS Confirmed Robust Clinical Benefits And Safety
Of COPAXONE(R)
|
| 09-19-08
|
New
Long-Term Data Show That Patients Taking AVONEX/(R) For Up To 15 Years
Experience Reduced Disability Progression And Improved Quality Of Life
|
| 09-19-08
|
Laquinimod
Demonstrated Significant And Sustained Impact On Multiple Sclerosis
Disease Activity
|
| 09-19-08
|
Journal
Of Clinical Investigation: Sept. 18, 2008
|
| 09-20-08
|
New
Data Presented At WCTRIMS Supports The Importance Of Early And
Sustained Treatment With Betaseron(R)
|
| 09-21-08
|
Additional
Data From Second Positive Phase 3 Study Of Fampridine-SR At World
Congress On Treatment And Research In Multiple Sclerosis
|
| 09-22-08
|
Opexa
Announces Top-Line Results From Phase IIb Clinical Trial Of Tovaxin(R)
For The Treatment Of Multiple Sclerosis
|
| 09-22-08
|
TYSABRI(R)
Demonstrates Sustained Improvement In Functional Outcomes In Multiple
Sclerosis Patients According To New Post-Hoc Analysis
|
| 09-22-08
|
Society
Joins Medical Research Awards
|
| 09-23-08
|
ATL/TV1102
Trial Results Presented At World Congress On Treatment And Research In
Multiple Sclerosis
|
| 09-23-08
|
Results
From IMPROVE Study Show Therapeutic Effect Of New Formulation Of
Rebif(R) At 16 Weeks In Patients With Multiple Sclerosis
|
| 09-24-08
|
MS
Society Welcomes Labour's Commitment On Prescription Charges, UK
|
| 09-24-08
|
Merck
Serono Completes Enrollment In The REFLEX Trial Of Rebif(R) In Patients
At Risk Of Developing Multiple Sclerosis
|
| 09-24-08
|
Show
Therapeutic Effect Of New Formulation Of Rebif(R) At 16 Weeks In
Patients With Multiple Sclerosis
|
| 09-25-08
|
European
Medicines Agency Recommends Update Of Product Information OfTysabri And
Risk Of Progressive Multifocal Leukoencephalopathy (PML)
|
| 09-26-08
|
Five
Year Data Confirm That Early Treatment With Betaferon® At First Sign Of
Disease Can Delay Progression To MS
|
| 09-26-08
|
The
Majority Of Children Vaccinated Against Hepatitis B Are Not At
Increased Risk Of MS
|
| 09-30-08
|
Suspicious Immune Molecule Elevated In MS Patients
|
